EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudieOpen Access · CC BY-NC 4.0

Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis

Xinyue Zhang iD, Jie Yang iD, Sijian Li iD, Tianyu Zhang iD, Jiaxin Yang iD

Journal of Gynecologic Oncology · 2025

DOI: 10.3802/jgo.2025.36.e49 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Xinyue Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospita…. Hauptthemen laut MEDLINE: Cisplatin, Carboplatin, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National High-Level Hospital Clinical Research Funding, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, NKRDPC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate the role of carboplatin-based chemotherapy in patients diagnosed with malignant gonadal germ cell tumors (GCTs), we conducted a systematic review and meta-analysis. We searched PubMed, MEDLINE, Embase, Cochrane library, and Web of Science. Randomized controlled trials or cohort studies on gonadal GCTs between January 1, 1970 and April 26, 2023 were enrolled. The treatment failure rate and mortality rate were the primary outcomes. Subgroup analysis based on the primary tumor site and dose of carboplatin was also conducted. In total, 8 studies with 1,409 patients were included. Compared to cisplatin-based chemotherapy, carboplatin-based chemotherapy had an increased treatment failure rate (odds ratio [OR]=2.23; 95% confidence interval [CI]=1.61-3.08; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinCarboplatinNeoplasms, Germ Cell and EmbryonalTesticular NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsOvarian NeoplasmsAntineoplastic AgentsHumansMaleFemaleRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

CarboplatinCisplatinGerm Cell TumorMortalityTreatment Failure

Substanzen

CisplatinCarboplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College,…

ORCID-Profile: Xinyue Zhang, Jie Yang, Sijian Li, Tianyu Zhang, Jiaxin Yang

Förderung

  • National High-Level Hospital Clinical Research Funding
  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
  • NKRDPC
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, X., Yang, J., Li, S., Zhang, T., & Yang, J. (2025). Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e49

Vancouver

Zhang X, Yang J, Li S, Zhang T, Yang J. Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e49

BibTeX
@article{Zhang2025,
  author = {Zhang, Xinyue and Yang, Jie and Li, Sijian and Zhang, Tianyu and Yang, Jiaxin},
  title = {Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis},
  journal = {Journal of Gynecologic Oncology},
  year = {2025},
  doi = {10.3802/jgo.2025.36.e49}
}
Kostenlos starten →